Dr. Romancik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd NE Bldg B
Atlanta, GA 30322Phone+1 404-712-1722Fax+1 404-251-1899
Education & Training
- Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2018 - 2021
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2015 - 2018
- Rush Medical College of Rush University Medical CenterClass of 2015
Certifications & Licensure
- GA State Medical License 2021 - 2026
- MO State Medical License 2015 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 50 citationsAllogeneic transplantation after PD-1 blockade for classic Hodgkin lymphomaReid W. Merryman, Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini
Leukemia. 2021-03-03 - 53 citationsSingle-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.Victor M. Orellana-Noia, Daniel R Reed, A. Mccook, Jeremy M Sen, Christian M Barlow
Blood. 2021-09-27 - 17 citationsTafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.David A Qualls, Nicholas Lambert, Paolo F Caimi, Mwanasha Merrill, Priyanka Pullarkat
Blood. 2023-12-28
Abstracts/Posters
- Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...Jason Romancik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin LymphomaJason Romancik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: